Page last updated: 2024-08-24

gemcitabine and Type 2 von Willebrand Disease

gemcitabine has been researched along with Type 2 von Willebrand Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dumas, G; Goldwasser, F; Rodrigues, MJ; Rousseau, B; Tlemsani, C	1

Other Studies

1 other study(ies) available for gemcitabine and Type 2 von Willebrand Disease

Article	Year
Acquired Type II von Willebrand Syndrome in Locally Advanced Bladder Cancer Successfully Treated With Intravenous Immunoglobulin and Chemotherapy. Clinical genitourinary cancer, 2016, Volume: 14, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Humans; Immunoglobulins, Intravenous; Lymphatic Metastasis; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Radiography; Urinary Bladder Neoplasms; von Willebrand Disease, Type 2	2016

Article

Year

Acquired Type II von Willebrand Syndrome in Locally Advanced Bladder Cancer Successfully Treated With Intravenous Immunoglobulin and Chemotherapy.

Clinical genitourinary cancer, 2016, Volume: 14, Issue:1

Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Humans; Immunoglobulins, Intravenous; Lymphatic Metastasis; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Radiography; Urinary Bladder Neoplasms; von Willebrand Disease, Type 2

2016